Quantcast

Horizon Pharma plc to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference

By GlobeNewswire,  May 30, 2018, 08:00:00 AM EDT


DUBLIN, Ireland, May 30, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), today announced that the company will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018 and will present at 10:40 a.m. PT.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases.  By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians.  For us, it's personal:  by living up to our own potential, we are helping others live up to theirs.  For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

                                                                                                                                      

Contacts:

Investors:                                                                     U.S. Media:

Tina Ventura                                                                  Geoff Curtis

Senior Vice President,                                                   Senior Vice President,

Investor Relations                                                          Corporate Affairs & Chief Communications Officer

investor-relations@horizonpharma.com                        media@horizonpharma.com

Ruth Venning                                                                  Ireland Media:

Executive Director,                                                          Ray Gordon

Investor Relations                                                           Gordon MRM   

investor-relations@horizonpharma.com                         ray@gordonmrm.ie

Source: Horizon Pharma plc

This article appears in: News Headlines

Referenced Stocks: HZNP








Today's Market Activity

NASDAQ 7870.89
51.18  ▲  0.65%
DJIA 25299.92
112.22  ▲  0.45%
S&P 500 2839.96
18.03  ▲  0.64%
Data as of Aug 14, 2018